In a murine ovarian cancer study, tumor-derived β-defensin, in cooperation with VEGF, also recruits a CD34−CD8α− MHC-IIloCD11chiCD11bhi DC subset which promotes tumor neovascularization and T cell exclusion (70). The gene discussed is HLA-C; the disease is neoplasm.